Botulinum toxin type a versus phenol. A clinical and neurophysiological study in the treatment of ankle clonus

European Journal of Physical and Rehabilitation Medicine

Volumn 46, Issue 1, 2010, Pages 11-18

  Manca, M ^a   Merlo, A ^b   Ferraresi, G ^a   Cavazza, S ^a   Marchi, P ^a  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^b PATHOLOGY UNIT   (Italy)

Author keywords

Ankle clonus; Botulinum toxins; H reflex; Nerve block

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT; PHENOL;

ADOLESCENT; ADULT; AGED; ANKLE; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; JOINT CHARACTERISTICS AND FUNCTIONS; MALE; METHODOLOGY; MIDDLE AGED; NERVE BLOCK; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SPASTIC PARAPLEGIA;

ADOLESCENT; ADULT; AGED; ANKLE; BOTULINUM TOXIN TYPE A; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE BLOCK; NEUROMUSCULAR AGENTS; PARAPARESIS, SPASTIC; PHENOL; RANGE OF MOTION, ARTICULAR;

EID: 77952298674     PISSN: 19739087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Glenn MB. Nerve blocks. In: Glenn MB, Whyte J, editors. The practical management of spasticity in children and adults. Philadelphia, PA: Ed. Lea & Febiger; 1990. p. 227-58.
2. Simpson DM. Clinical trials of botulinum toxin in the treatment of spasticity. Muscle Nerve 1997 (Suppl 6): S169-S75.
3. Brin MF, and Spasticity Study Group. Dosing, administration and a treatment algorithm for use of botulinum toxin for adult onset spasticity. Muscle Nerve 1997; (Suppl 6): S208-20.
4. Carda S, Molteni F. Selective neuromuscular blocks and chemoneurolysis in the localized treatment of spasticity. Eur Medicophys 2004;40:123-30.
5. Cormack J, Powers CM. Is there evidence that botulinum toxin injections are more effective than phenol injections in relieving poststroke reflex activity during plantar flexion, thereby increasing ankle range of motion and improving gait function.? Phys Ther 2004;84:76-84.
6. Kirazli Y, On AY, Kismali B, Aksit R. Comparison of phenol block and Botulinum toxin type A in the treatment of spastic foot after stroke. Am J Phys Med Rehabil 1998;6:510-5.
7. On AY, Kirazli Y, Kismali B, Aksit R. Mechanisms of action of phenol block and botulinum toxin Type A in relieving spasticity: electrophysiologic investigation and follow-up. Am J Phys Med Rehabil 1999;78:344-9.
8. van Kuijk AA, Geurts AC, Bevaart BJ, van Limbeek J. Treatment of upper extremity spasticity in stroke patients by focal neuronal or neuromuscular blockade: a systematic review of the literature. J Rehabil Med 2002;34:51-61.
9. Wong A M K, Chen CL, Chen C P C, Chou SW, Chung CY, Chen M J L. Clinical effects of botulinum toxin A and phenol block on gait in children with cerebral palsy. Am J Phys Med Rehabil 2004;83:284-91.
10. Clarkson HM, Gilewich GB. Musculoskeletal assessment. Joint range of motion and manual muscle strength. Baltimora, MD: Willliams & Wilkins; 1989.
11. Tardieu G, Shentoub S, Delarue R. A la recherche d'une technique de mesure de la spasticité. Rev Neurol 1954;91:143-4.
12. Kimura J. The H reflex and other late response. In: Kimura J, editor. Electrodiagnosis in diseases of nerve and muscle: principle and practice. Philadelphia, PA: FA Davis Company; 1983. p. 379-98.
13. Francisco GE. Botulinum toxin: dosing and dilution. Am J Phys Med Rehabil 2004;83(Suppl): S30-S7.
14. Petrillo CR, Knoploch S. Phenol block of the tibial nerve for spasticity: a long-term follow-up study. Int Disabil Stud 1988;10:97-100.
15. Pandyan AD, Johnson GR. A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity. Clin Rehabil 1999;13:373-83.
16. Blackburn M, van Vliet P, Mockett SP. Reliability of measurements obtained with the modified Ashworth scale in the lower extremities of people with stroke. Phys Ther 2002;82:25-34.
17. Patrick E, Ada L. The Tardieu scale differentiates contracture from spasticity whereas the Ashworth scale is confounded by it. Clin Rehabil 2006;20:173-82.
18. Lagalla G, Danni M, Reiter F, Ceravolo MG, Provinciali L. Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb. Am J Phys Med Rehabil 2000;79:377-84.
19. Grades JM. Physiological effects of botulinum toxin in spasticity. Mov Disord. 2004;19(Suppl 8): S120-8.
20. McCrea PH, Eng JJ, Willms R. Phenol reduces hypertonia and enhances strength: a longitudinal case study. Neurorehabil Neural Repair 2004;18:112-6.
21. Miscio G, Del Conte C, Pianca D, Colombo R, Panizza M, Schieppati M et al. Botulinum toxin in post-stroke patients: stiffness modifications and clinical implications. J Neurol 2004;251:189-96.
22. Modugno N, Priori A, Berardelli A, Vacca L, Mercuri B, Manfredi M. Botulinum toxin restores presynaptic inhibition of group la afferents in patients with essential tremor. Muscle Nerve 1998;21:1701-5.
23. Filippi GM, Errico P, Santarelli R, Bagolini B, Manni E. Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol 1993;113:400-4.
24. Rosales RL, Arimura K, Takenaga S, Osame M. Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection. Muscle Nerve 1996;19:488-96.